期刊
CIRCULATION-CARDIOVASCULAR GENETICS
卷 8, 期 1, 页码 187-191出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCGENETICS.114.000219
关键词
cardiovascular disease; diabetes mellitus; metabolomics; microbiome; obesity; trimethylamine-N-oxide
资金
- MRC (Lipid Profiling and Signalling program grant) [UD99999906]
- BBSRC [Bb/H013539/2, bb/I000933/I]
- National Institutes of Health [ES022186, PENTACON]
- Wellcome Trust
- British Heart Foundation
- Biotechnology and Biological Sciences Research Council [BB/H013539/2] Funding Source: researchfish
- Medical Research Council [MC_UP_A090_1006] Funding Source: researchfish
- BBSRC [BB/H013539/2] Funding Source: UKRI
- MRC [MC_UP_A090_1006] Funding Source: UKRI
Millions of microbes are found in the human gut, and are collectively referred as the gut microbiota. Recent studies have estimated that the microbiota genome contains 100-fold more genes than the host genome. These microbiota contribute to digestion by processing energy substrates unutilized by the host, with about half of the total genome of the gut microbiota being related to central carbon and amino acid metabolism as well as the biosynthesis of secondary metabolites. Therefore, the gut microbiome and its interaction with the host influences many aspects of health and disease, including the composition of biofluids such as urine and blood plasma. Metabolomics is uniquely suited to capture these functional host-microbe interactions. This review aims at providing an overview of recent metabolomics evidence of gut microbiota-host metabolic interactions with a specific focus on cardiovascular disease and related aspects of the metabolic syndrome. Furthermore, the emphasis is given on the complexities of translating these metabolite signatures as potential clinical biomarkers, as the composition and activity of gut microbiome change with many factors, particularly with diet, with special reference to trimethylamine-oxide.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据